definiens: means any biopharmaceutical product that consists of ( i ) a component that is a Licensed Product and one or more other active ingredients, products, procedures, delivery mechanisms or devices, or componen ts sold as a single formulation or ( ii ) any combination of a Licensed Product sold together with one or more other products or components for a single invoiced price . If a Licensed Product is sold as part of a Combination Product in a country in the Terri tory, Net Sales for the Licensed Product included in such Combination Product in such country shall be calculated as follows : ( a ) If the Licensed Product is sold separately in such country and the other active ingredient ( s ), product(s ), procedure(s ), delivery mechanism(s ) or device(s ), or component(s ) in the Combination Product are sold separately in such country, Net Sales for the Licensed Product shall be calculated by multiplying actual Net Sales of such Combination Pro duct in such country by the fraction A/(A+B ), where A is the invoice price of the Licensed Product when sold separately in such country and B is the total invoice price of the other active ingredient(s ), product(s ), procedure(s ), delivery mechanism(s ) or device(s ), or component(s ) in the Combination Product when sold separately in such country ; ( b ) If the Licensed Product is sold separately in such country but the other active ingredient(s ), product(s ), procedure(s ), delivery mechanism(s ) or device(s ), or component(s ) in the Combination Product are not sold separately in such country, Net Sales for the Licensed Product shall be calculated by multiplying actual Net Sales of such Combination Product in such country by th e fraction A / D, where A is the invoice price of the Licensed Product when sold separately in such country and D is the invoice price of the Combination Product in such country ; ( c ) If the Licensed Product is not sold sepa rately in such country but the other active ingredient(s ), product(s ), procedure(s ), delivery mechanism(s ) or device(s ), or component(s ) in the Combinations Product are sold separately in such country, Net Sales for the Licensed Product shall be calculated by multiplying actual Net Sales of such Combination Product by the fraction 1 — ( B / D ), where B is the invoice price of the other active ingredient(s ), product(s ) or component(s ) in the Combination Product when sold separately in such country and D is the invoice price of the Combination Product in such country ; or 3 ( d ) If neither the Licensed Product nor the other active ingredient(s ), product(s ), procedure(s ), delivery mechanism(s ) or device(s ), or component(s ) in the Combination Product are sold separately in such country, the Parties shall determine Net Sales for the Licensed Product in such Combination Product by mutual agreement based on the relative contribution of the Licensed Product and each other active ingre dient, product, procedure, delivery mechanism or device, or component to the Combination Product, and shall take into account in good faith any applicable allocations and calculations that may have been made for the same period in other countries ; provided, however, if the Parties can not agree on the Net Sales for the Licensed Product in such Combination Product after good faith negotiations, the Net Sales for the Licensed Product shall be calculated by dividing the actual Net Sales of such Combination Product by the total number of active ingredients, products, procedures, delivery mechanisms or devices, or components ( including the Licensed Product ) in such Combination Product